三阴性乳腺癌复发性脑转移:68Ga-PSMA-11 PET/CT高摄取
本文报道一例47岁女性三阴性乳腺癌(TNBC)患者,出现复发性脑转移灶,该病灶在68Ga-PSMA-11 PET/CT上呈高摄取,而18F-FDG摄取较低。作者指出TNBC预后差、对标准治疗反应有限,FDG PET/CT因肿瘤异质性有时不够充分;PSMA在多种肿瘤相关新生血管中过表达,68Ga-PSMA-11 PET/CT可用于显示TNBC的原发灶、复发灶及放射性核素治疗可能性。
要点
- TNBC复发性脑转移灶可表现为68Ga-PSMA-11高摄取而FDG低摄取。
- FDG PET/CT在TNBC中可因肿瘤异质性而显像不足。
- 68Ga-PSMA-11 PET/CT可能提示TNBC的放射性核素治疗选择。
核心结论
- TNBC复发性脑转移灶可呈68Ga-PSMA-11高摄取,而FDG摄取较低。
研究设计与样本
- 个案报道:一例47岁女性TNBC患者,行68Ga-PSMA-11 PET/CT与18F-FDG PET/CT显像。
主要发现
- 复发性脑转移灶显示PSMA受体活性高摄取,FDG摄取低。
临床怎么用
- 对TNBC怀疑复发或转移且FDG PET/CT结果不充分时,可考虑68Ga-PSMA-11 PET/CT评估PSMA表达。
局限性
- 仅为单个病例报道,结论不能外推至全部TNBC患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Triple negative breast cancer (TNBC) is characterized by poor prognosis and limited response to standard treatments. Although 18F-FDG PET/CT is frequently used in staging and restaging, in some cases, it may be insufficient considering tumor heterogeneity. Prostate-specific membrane antigen (PSMA) has been reported to be overexpressed in many types of cancer due to tumor-associated neovascularization. 68Ga-PSMA-11 PET/CT can be used to demonstrate radionuclide therapy option as well as detection of primary tumor and recurrence in TNBC. We present a 47-year-old woman with TNBC having recurrent brain metastasis with avid PSMA receptor activity versus low FDG uptake.
引用
- Arslan E, Ergül N, Karagöz Y, et al. Recurrent Brain Metastasis of Triple Negative Breast Cancer With High Uptake in 68Ga-PSMA-11 PET/CT. Clin Nucl Med. 2021. PMID: 33065618. doi:10.1097/RLU.0000000000003336
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。